在帕金森病中,振荡性与非振荡性亚thalamicβ活性之间的比较
Jesús Pardo-Valencia1,2, Carla Fernández-García1, Fernando Alonso-Frech1,3
1HM CINAC (Centro Integral de Neurociencias Abarca Campal), Hospital Universitario HM Puerta del Sur, HM Hospitales, Madrid, Spain.
The Journal of physiology
|December 12, 2023
概括
在帕金森病中,过度的β活性有两个组成部分:振荡和非振荡. 只有振荡成分是多巴胺依赖的,与较快的运动进展相关,为适应性深度大脑刺激提供了洞察力.
科学领域:
- 神经科学是一个神经科学.
- 生物医学工程 生物医学工程
背景情况:
- 帕金森病 (PD) 与运动电路中β活性 (13-35 Hz) 的升高有关.
- 贝塔活动包括振荡 (周期性) 和非振荡 (非周期性,尖端) 组件.
- 这些β组分的不同作用,多巴胺依赖性和临床相关性尚未完全理解.
研究的目的:
- 在PD中区分和量化β活动的振荡和非振荡元件.
- 为了研究每个β活性成分的多巴胺依赖性.
- 为了将这些组成部分与疾病进展和运动症状相关联.
主要方法:
- 从PD患者中记录了亚thalamic局部场潜力,无论是在药物治疗中还是在药物治疗中.
- 使用1 / f噪声的自回归建模用于分离振荡和非振荡活动.
- 贝叶斯分析评估了药物效应和临床相关性.
主要成果:
- 模型分析显示,爆发持续时间和光谱度是振荡活动特有的,而振幅和功率是模两可的.
- 利沃多巴治疗显著降低了振荡β活性,但对非振荡β活性没有明显的影响.
- 波动β活性增加与PD患者的运动进展加快有很强的相关性.
结论:
- 振荡β活性是PD中主要的多巴胺依赖成分.
- 振荡β活性是帕金森病中运动进展的关键生物标志物.
- 这些发现增强了对贝塔生物标志物的理解,用于PD的适应性深度大脑刺激.
更多相关视频
10:46Acute In Vivo Electrophysiological Recordings of Local Field Potentials and Multi-unit Activity from the Hyperdirect Pathway in Anesthetized Rats
Published on: June 22, 2017
15.7K
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.7K
相关概念视频
Parkinson's Disease: Treatment
274
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
274
Parkinson's Disease: Overview
556
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
556
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
